№ files_lp_3_process_7_083045
File format: docx
Character count: 23227
File size: 115 KB
This document provides a series of questions and answers related to pharmaceutical practices, focusing on drug dosage, classifications, and pharmacy regulations.
Year:
2008
Region / City:
United States
Topic:
Pharmaceutical practice, medication dosage, pharmacy regulations
Document Type:
Educational material
Author:
Not specified
Target Audience:
Pharmacists, pharmacy technicians, medical professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Medicine name:
Gliclazide
Therapeutic class:
Oral hypoglycaemic agent
Indications:
Type 2 diabetes; monogenic diabetes; steroid-induced diabetes
Form:
Tablet
Administration:
Once or twice daily with food
Dose adjustment:
According to blood glucose levels under medical supervision
Common adverse effects:
Nausea; diarrhoea; constipation; weight gain
Serious adverse effects:
Hypoglycaemia; liver dysfunction; blood cell disorders
Contraindications:
Type 1 diabetes; severe kidney disease; severe liver disease; pregnancy; breastfeeding; concomitant miconazole use; porphyria
Driving regulations:
Notification required to DVLA for Group 2 licence holders
Monitoring requirements:
Regular blood glucose monitoring; mandatory monitoring for Group 2 drivers during driving
Issuing institution:
Edinburgh Centre for Endocrinology and Diabetes
Document type:
Patient information leaflet
Geographical reference:
United Kingdom
Year:
2016
Region / city:
Not specified
Topic:
Genetics, Plant Biology
Document Type:
Research Article
Institution:
Not specified
Author:
Piotr A. Ziolkowski, Charles J. Underwood, Christophe Lambing, Marina Martinez-Garcia, Emma J. Lawrence, Liliana Ziolkowska, Catherine Griffin, Kyuha Choi, F. Chris H. Franklin, Robert A. Martienssen, Ian R. Henderson
Target Audience:
Researchers, Academics
Period of Action:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2020
Region / city:
Peshawar
Subject:
Laboratory equipment purchase
Document type:
Tender
Organization:
The University of Agriculture, Peshawar
Author:
Not specified
Target audience:
Registered firms, suppliers, authorized distributors
Period of validity:
90 days from bid opening
Approval date:
03-01-2020
Date of changes:
20-01-2020
Tender submission deadline:
20-01-2020, 01:45 p.m.
Tender opening date:
20-01-2020, 02:00 p.m.
Tender fee:
Rs. 500
Earnest money:
2% of tender cost
Warranty period:
1 year
Bid validity period:
90 days
Bid bond requirement:
3% of quoted price
Note:
Document type
Tender notice
Description:
A tender notice for the purchase of laboratory equipment (Spectrophotometer) for a research project at The University of Agriculture, Peshawar, including conditions for submission and specifications.
Note:
Year
Topic:
Dosage calculation
Document type:
Educational material
Target audience:
Healthcare professionals
Year:
2026
Region / City:
Not specified
Subject:
Pharmacology, Dosage Calculation
Document Type:
Educational / Reference Material
Institution / Organization:
Not specified
Author:
Not specified
Target Audience:
Healthcare professionals, nursing students
Measurement Units:
grams, milligrams, micrograms, milliliters, units
Dosage Forms:
Tablets, capsules, syrup, injections
Calculation Methods:
Conversion, ratio, rate, drip calculation
Contextual Period:
Present clinical practice
Prescription Examples Included:
Yes
Year:
2015
Institution:
NHS
Document Type:
Medical administration record
Subject:
Fluid and food thickener usage
Resident Name:
[To be filled]
Date of Birth:
[To be filled]
Product:
[To be filled]
Date Opened:
[To be filled]
Use By Date:
[To be filled]
IDDSI Step:
Step 1, Step 2, Step 3, Step 4
Number of Scoops per 200ml:
[To be filled]
Completed By:
[To be filled]
Checked By:
[To be filled]
Reference:
PSA Alert NHS/PSA/W/2015/002
URL:
https://www.england.nhs.uk/wp-content/uploads/2019/12/psa-thickening-agents.pdf
Year:
2025
Region / City:
Dorset, BCP Council
Theme:
Pharmaceutical Services, Health Needs Assessment
Document Type:
Draft Report
Organization:
Public Health Dorset
Author:
Jane Horne, Lee Robertson, Wilson Otitonaiye, Rohan Mongru, Fiona Arnold, Louise Bate
Target Audience:
Health professionals, policymakers, local authorities
Period of Validity:
2025-2028
Approval Date:
Draft version, ongoing review
Date of Last Update:
04/06/2025
Context:
This document provides a comprehensive pharmaceutical needs assessment for the Dorset area, focusing on the supply, demand, and gaps in pharmaceutical services over the period 2025-2028.
Year:
2014
Region / City:
Global
Topic:
Pharmaceutical Product Prequalification
Document Type:
Guideline
Organization / Institution:
World Health Organization (WHO)
Author:
World Health Organization
Target Audience:
Pharmaceutical manufacturers, regulatory bodies
Effective Period:
Not specified
Approval Date:
2014
Modification Date:
Not specified
Note:
Year
Topic:
Pharmaceutical product, regulatory approval, prequalification
Document type:
Template
Organization / institution:
WHO
Target audience:
Regulatory authorities, pharmaceutical manufacturers
Year:
2023
Region / City:
United Kingdom
Topic:
Pharmaceutical guidance
Document type:
Consultation response
Organization:
Royal Pharmaceutical Society
Author:
Royal Pharmaceutical Society
Target audience:
Pharmacy professionals, regulatory bodies, pharmacy service owners
Action period:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
HDA Standard Pharmaceutical (Rx-only) Product and Medical Device Information Short Form Instructions
Note:
Year
Theme:
Pharmaceutical products, Medical devices
Document type:
Instructions, Form
Organization / Institution:
HDA
Target audience:
Distributors, Manufacturers, Supply chain professionals
Document type:
Regulatory template appendix
Subject:
Quality information summary for finished pharmaceutical products and vaccines
Procedure:
Reference SRA collaborative procedure
Regulatory framework:
WHO Guidelines on submission of documentation for prequalification
Issuing organization:
World Health Organization
Series:
WHO Technical Report Series
Series number:
No. 1010
Year:
2018
Scope:
Pharmaceutical products and vaccines approved by stringent regulatory authorities
Intended use:
National registration under the SRA collaborative procedure
Confidentiality status:
Includes confidential quality information
Approval basis:
Information as approved by the reference SRA
Change management:
Revision required upon approved variations affecting QIS-SRA (crp)
Organization:
World Health Organization; South African Health Products Regulatory Authority
Document type:
Regulatory guideline
Subject area:
Pharmaceutical quality documentation
Scope:
Multisource (generic) finished pharmaceutical products and active pharmaceutical ingredients
Applicable products:
Human medicines; biologics; veterinary medicines
Regulatory references:
WHO TRS 970 Annex 6; VICH guidelines; European Pharmacopoeia; USP; BP
Geographical applicability:
International; South Africa
Related regulatory procedures:
API Prequalification; CEP; APIMF; product dossier submission
Content focus:
Quality data requirements; labelling and product information; drug substance characterization
Intended users:
Marketing authorization applicants; regulatory assessors
Year:
2021
Region / City:
United States
Topic:
Pharmaceutical and Medical Device Product Information
Document Type:
Instructional Form
Organization / Institution:
Health Distribution Alliance (HDA)
Author:
Health Distribution Alliance
Target Audience:
Pharmaceutical distributors, medical device manufacturers, suppliers
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
2021
Year:
2023
Region / City:
Falkirk
Theme:
Health & Social Care, Pharmacy, Medication Management
Document Type:
Policy
Organization:
Falkirk Health & Social Care Partnership
Author:
Not specified
Target Audience:
Community pharmacies, care at home providers, healthcare professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2022
Region / city:
Great Britain
Topic:
Remote hearings, Pharmacy, Patient safety
Document type:
Response to consultation
Organization:
Royal Pharmaceutical Society
Author:
Jonathan Lloyd Jones
Target audience:
General Pharmaceutical Council, Pharmacy professionals, Stakeholders
Validity period:
N/A
Approval date:
February 7, 2022
Amendment date:
N/A
Year:
2025
Region / City:
Australia
Topic:
Pharmaceutical benefits, chemotherapy, PBS
Document Type:
FAQ
Organization:
Pharmaceutical Benefits Scheme
Author:
Pharmaceutical Benefits Advisory Committee (PBAC)
Target Audience:
Healthcare providers, prescribers, patients
Effective Period:
From December 1, 2024
Approval Date:
Not specified
Modification Date:
Not specified
Contextual Description:
FAQ document providing detailed information on the changes in PBS listing for Opdualag and Vyxeos under the EFC Program, including prescription and claiming details.
Year:
2023
Country:
United Kingdom
Organisation:
Royal Pharmaceutical Society
Document type:
Evidence submission
Topic:
Inclusion and diversity in pharmacy services
Population focus:
LGBTQ+ communities
Methodology:
Mixed-methods survey and literature review
Sample size:
620 survey respondents
Data sources:
RPS I&D Programme evaluation survey; published academic studies
Status:
Unpublished internal survey with referenced published research
Scope:
Community and pharmacy professional services
Context:
Evidence submission to an LGBT+ health review drawing on an internal inclusion and diversity survey and recent pharmacy-focused research to describe experiences, barriers, and attitudes related to LGBTQ+ access to pharmacy services in the UK.
Year:
2026
Region / City:
United Kingdom
Topic:
Genomics Education, Pharmacogenomics, NHS Workforce Development
Document Type:
Written Evidence Submission
Organization / Institution:
Royal Pharmaceutical Society
Author:
Royal Pharmaceutical Society
Target Audience:
NHS professionals, educational providers, healthcare policy makers
Period of Action:
2026-2030
Approval Date:
2026
Date of Amendments:
N/A
Note:
Year
Topic:
Pharmaceutical product certification
Document Type:
Certificate
Authority / Organization:
Health Products Regulatory Authority (HPRA)
Target Audience:
Regulatory authorities, pharmaceutical companies